NCT01637246CompletedNot Applicable
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Allergan
- Enrollment
- 4,385
- Primary Endpoint
- Change From Baseline in Intraocular Pressure (IOP)
Study Overview
Brief Summary
This is a retrospective chart review and will assess changes in IOP after treatment with any fixed combination in patients who previously received monotherapy.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Diagnosis of glaucoma or ocular hypertension
- •Previously treated with monotherapy followed by fixed combination therapy for at least 12 weeks
Exclusion Criteria
- Not provided
Arms & Interventions
POAG or OHT
Patients with POAG or OHT previously treated with monotherapy and currently treated with any fixed combination therapy
Intervention: Any Fixed Combination Therapy (Drug)
Outcomes
Primary Outcomes
Change From Baseline in Intraocular Pressure (IOP)
Time Frame: Baseline, 12 Weeks
IOP is a measurement of the fluid pressure inside the eye. A negative change from baseline indicates an improvement.
Secondary Outcomes
- Physician Assessment of Tolerability Using a 4-Point Scale(12 Weeks)
- Percentage of Patients Who Maintained Better Compliance With Treatment(12 Weeks)
- Patient Assessment of Tolerability Using a 4-Point Scale(12 Weeks)
- Percentage of Patients Continuing on Therapy After 12 Weeks(12 Weeks)
Investigators
Similar Trials
Completed
Not Applicable
A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Switched to Lumigan® UD Monotherapy for Medical ReasonsGlaucoma, Primary Open AngleOcular HypertensionNCT01853085Allergan1,830
Terminated
Not Applicable
A Prospective Evaluation of Glaucoma Subjects Treated With Two Second Generation iStents and One iStent SupraGlaucoma, Open-AngleNCT03255798Glaukos Corporation7
Completed
Not Applicable
An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering TreatmentsGlaucoma, Open-AngleOcular HypertensionNCT01735214Allergan358
Completed
Phase 4
Prospective Evaluation of Open-Angle Glaucoma Subjects on One Topical Hypotensive Medication Treated With Two iStentsSubjects With Primary Open-angle Glaucoma (POAG)NCT01252862Glaukos Corporation40
Completed
Phase 4
A Prospective, Unmasked Evaluation of the iStent in Patients With Primary Open-Angle GlaucomaGlaucomaEye DiseasesGlaucoma, Open-AngleNCT00911924Glaukos Corporation112